Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: th
Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: th
Claudio Coco, Alice Moroni, Judith Cohen, Maria Gnoli et al.
Journal
BMJ Open
Topics
Connective tissue disorders research
article
Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: th
Claudio Coco, Alice Moroni, Judith Cohen, Maria Gnoli, Chao Huang, Martina Piccinni Leopardi, Charlotte Heath, L. Moody Simms, Bronwen Williams, Luca Sangiorgi, Mahboobeh Haji Sadeghi, Nick Bishop, Sarah Sumpter, Keith Pugh, A R Wilkinson, Francesca Gurioli
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(12)
Institutions
University of Hull (GB), Sheffield Children's NHS Foundation Trust (GB), Istituto Ortopedico Rizzoli (IT), University of Sheffield (GB)
Funders
Children's National Hospital, European Commission, HORIZON EUROPE Framework Programme